1-20 of 63
certified occupational therapy assistant
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Results of the iR 2 Regimen (Ibrutinib, Lenalidomide, and Rituximab) in Patients with Relapsed/Refractory (R/R) Non-Germinal Center B Cell-like (Non-GCB) Diffuse Large B-Cell Lymphoma (DLBCL)

Radhakrishnan Ramchandren, MD, Peter Johnson, MDFRCP, Nilanjan Ghosh, MD PhD, Jia Ruan, MD PhD, Kirit M. Ardeshna, MA, MD FRCP, FRCPath, Roderick Johnson, MD, Gregor Verhoef, MD PhD, David Cunningham, MD FRCP, FMedSci, Sven de Vos, MD PhD, Shireen Kassam, MD, Luis Fayad, MD, John Radford, Sarah Bailly, MD, Fritz Offner, MD, David Morgan, MD, Javier Munoz, MD, Jerry Ping, PhD, Kevin Kwei, PhD, Karl Eckert, BA, Jutta K. Neuenburg, MD PhD, Andre Goy, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 761.
https://doi.org/10.1182/blood-2019-121521
Published: 2019
Journal Articles

Experience with Axicabtagene Ciloleucel (Axi-cel) in Patients with Secondary CNS Involvement: Results from the US Lymphoma CAR T Consortium

N. Nora Bennani, MD, Matthew J. Maurer, MS, Loretta J. Nastoupil, MD MSc, Michael D. Jain, MD PhD, Julio C. Chavez, MD, Amanda F Cashen, MD, Saurabh Dahiya, MD, Lazaros J. Lekakis, MD, Patrick M Reagan, MD, Olalekan O. Oluwole, MBBS, MPH, Joseph P. McGuirk, DO, Abhinav Deol, MD, Alison R. Sehgal, MD, Andre Goy, MD, Brian T. Hill, MD, Khoan Vu, MD, Charalambos Andreadis, MD, Javier Munoz, MD MS, FACP, Aaron P. Rapoport, Julie M Vose, MDMBA, David B Miklos, MD PhD, Frederick L. Locke, MD, Sattva S Neelapu, MD, Yi Lin, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 763.
https://doi.org/10.1182/blood-2019-129097
Published: 2019
Journal Articles

Chromosome 1q Amplification Is Associated with a History of Prior Malignancies Among Patients Newly Diagnosed with Multiple Myeloma

Elizabeth B Lamont, MD MS, MMSc, Andrew J. Yee, MD, Stuart L. Goldberg, MD, Andrew D Norden, MD MPH, MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 2193.
https://doi.org/10.1182/blood-2019-125407
Published: 2019
Journal Articles

Cytogenetic and Molecular Response with First- and Second-Generation Tyrosine Kinase Inhibitor (TKI) Therapy in Simplicity: An Observational Study of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML)

Jorge E. Cortes, MD, Clara Chen, PhD BS, MS, Catherine Davis, PharmD, Stuart L. Goldberg, MD, Michael J. Mauro, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2929.
https://doi.org/10.1182/blood-2019-127959
Published: 2019
Journal Articles

Introduction of Chromosomal Translocation t(11; 14) and a p53 Deletion into Normal B Cell-Derived iPSCs to Elucidate the Cellular Origin of Myeloma Cells

Aki Yanagi, MS, Naohiro Tsuyama, PhD, Misaki Sugai, BS, Yu Abe, PhD, Yusuke Azami, MD, Yukari Yanai, MS, Akinobu Ota, PhD, Karnan Sivasundaram, PhD, Moe Muramatsu, BS, Tomonari Shigemura, MD PhD, Megumi Sasatani, PhD, Yuko Hashimoto, MD PhD, Kenji Kamiya, MD PhD, Ichiro Hanamura, MD PhD, Takayuki Ikezoe, MD PhD, Masafumi Onodera, MD PhD, Akira Sakai, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3057.
https://doi.org/10.1182/blood-2019-122344
Published: 2019
Journal Articles

Characteristics and Outcomes of Patients Receiving Bridging Therapy While Awaiting Manufacture of Standard of Care Axicabtagene Ciloleucel CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymphoma CAR-T Consortium

Michael D. Jain, MD PhD, Miriam T. Jacobs, MD, Loretta J. Nastoupil, MD MSc, Jay Y. Spiegel, MDFRCPC, Gao Feng, Yi Lin, MD PhD, Matthew A. Lunning, DO, FACP, Saurabh Dahiya, MD, Lazaros J Lekakis, MD, Patrick M Reagan, MD, Olalekan O. Oluwole, MBBS, MPH, Joseph P. McGuirk, DO, Abhinav Deol, MD, Andre Goy, MD, Brian T. Hill, MD, Javier Munoz, MD, Julio Chavez, Aaron P. Rapoport, Julie M Vose, MDMBA, David B Miklos, MD PhD, Sattva S Neelapu, MD, N. Nora Bennani, MD, Charalambos Andreadis, MD MSCE, Alison R. Sehgal, MD, Armin Ghobadi, MD, Frederick L. Locke, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 245.
https://doi.org/10.1182/blood-2019-129624
Published: 2019
Journal Articles

Cardiovascular (CV)-Related Hospitalizations and Associated Costs Among US Patients in Simplicity: An Observational Study of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) in Routine Clinical Practice

Stuart L. Goldberg, MD, Michael J. Mauro, MD, Jorge E. Cortes, MD, Scott Justin Keating, MSc, BSc, Hitesh Bhandari, Clara Chen, PhD BS, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 4151.
https://doi.org/10.1182/blood-2019-128290
Published: 2019
Journal Articles

Engraftment Syndrome in the Setting of Autologous Stem Cell Transplantation for Multiple Myeloma-a Single Institution Review of over 600 Patients

Sudarsan Kollimuttathuliam, MD, Phyllis McKiernan, David S. Siegel, Scott D. Rowley, MD, Noa Biran, MD, David H. Vesole, MD PhD, Themba Nyirenda, PhD, Andrew L. Pecora, MD, Stuart L. Goldberg, MD, Andre Goy, MD, Michele L. Donato, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4576.
https://doi.org/10.1182/blood-2019-132052
Published: 2019
Journal Articles

Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World Patients

Maryam Sarraf Yazdy, MD, Anthony R. Mato, MDMSCE, Lindsey E. Roeker, MD, Umair Jarral, MD, Chaitra S. Ujjani, MD, Mazyar Shadman, MD MPH, Alan Skarbnik, MD, Kate J Whitaker, BA, Isaac Deonarine, Charlene C. Kabel, PharmD, Sarah E. Stump, PharmD, BCPS, BCOP, Julie Goodfriend, John M. Pagel, MD PhD DSc, Neil Bailey, MSc, Krish Patel, MD, Ryan Jacobs, MD, Tatyana A. Feldman, MD, Lori A. Leslie, MD, Andre Goy, MD, Catherine C. Coombs, MD, Benyam Muluneh, PharmD, Sirin Khajavian, MD, Nicole Lamanna, MD, Hanna Weissbrot, BS, Jessica Weiss, Bruce D. Cheson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4311.
https://doi.org/10.1182/blood-2019-130062
Published: 2019
Journal Articles

Blinatumomab in Combination with Tyrosine Kinase Inhibitors Safely and Effectively Induces Rapid, Deep, and Durable Molecular Responses in Relapsed and Refractory Philadelphia Positive Acute Leukemias

James K McCloskey, MD, Joelle Gagnon, NP, Tara McCabe, FNP-C, MSN, RN, BSN, Jocelyn Charlon, MS, AGPCNP-BC, Shuqi Wang, MSc, Ruzong Fan, Stuart L. Goldberg, MD, Jamie Koprivnikar, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3812.
https://doi.org/10.1182/blood-2019-131838
Published: 2019
Journal Articles

Sustained Hematopoietic Recovery after Salvage Autologous Stem Cell Transplants after Long Term Storage of Cryopreserved Hematopoietic Progenitor Stem Cells (HPSC)

Sarah S. Makhani, BA, Ronit Reich-Slotky, PhD, Pashna N. Munshi, MD, Noa Biran, MD, Michele L. Donato, MD, Stuart L. Goldberg, MD, Andrew L. Pecora, MD, David S. Siegel, David H. Vesole, MD PhD, Scott D. Rowley, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4475.
https://doi.org/10.1182/blood-2019-122111
Published: 2019
Journal Articles

Effect of Prior Therapy on the Efficacy and Safety of Oral Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Study

Federica Cavallo, MD PhD, George A Follows, MD PhD, Andre Goy, MD, Joost Vermaat, MD PhD, Rene-Olivier Casasnovas, MD, Orly Lavee, MD, Marie Maerevoet, MD, Josée M Zijlstra, MD PhD, Sameer Bakhshi, MD, Reda Bouabdallah, Sylvain Choquet, MD, Ronit Gurion, MD, Brian T. Hill, MD, Ulrich Jaeger, MD, Juan-Manuel Sancho, MD PhD, Michael W. Schuster, MD, Catherine Thieblemont, MD PhD, Fatima De la Cruz, MD, Miklos Egyed, MD PhD, Sourav Mishra, Fritz Offner, MD, Theodoros P. Vassilakopoulos, MD PhD, Krzysztof Warzocha, Daniel McCarthy, Xiwen Ma, Kelly Corona, Jean-Richard Saint-Martin, Anita Joshi, PhD, Jatin Shah, MD, Eric Van Den Neste, MD, Miguel A Canales, MD PhD, Nagesh Kalakonda, FRCPath PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5333.
https://doi.org/10.1182/blood-2019-122900
Published: 2019
Journal Articles

A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents: Treatment Patterns, Outcomes, and Patient-Reported Health-Related Quality of Life

Chaitra Ujjani, MD, Anthony R. Mato, MDMSCE, Jonathon B. Cohen, MDMS, Jakub Svoboda, MD, David Andorsky, MD, Andre Goy, MD, Michael L. Wang, MD, Anita Kumar, MD, Peggy Ann Torney, MS, Michelle Dawson, PhD, Cynthia Elesinmogun, PharmD, Shaum M Kabadi, PhDMPH, Brian Seal, MBA, PhD, John M. Pagel, MD PhD DSc, Scott D Ramsey, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5892.
https://doi.org/10.1182/blood-2019-122845
Published: 2019
Journal Articles

Severe Infections and Antibiotic Use Negatively Impact Progression Free and Overall Survival of Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Marshall McKenna, MD, Rena Feinman, PhD, Jaeil Ahn, PhD, Shuqi Wang, MSc, Elli Gourna Paleoudis, PhD, David H. Vesole, MD PhD, Stuart L. Goldberg, MD, Jun Chih Wang, MD, Abdul Rehman, MD, Giselle Alexandra Suero-Abreu, MD PhD, Phyllis McKiernan, Michele L. Donato, MD, Scott D. Rowley, MD, David S. Siegel, Noa Biran, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5510.
https://doi.org/10.1182/blood-2019-132134
Published: 2019
Journal Articles

Characteristics and Outcomes of Patients Who Did Not Develop CRS after Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymphoma CAR-T Consortium

Miriam T. Jacobs, MD, Michael D. Jain, MD PhD, Jay Y. Spiegel, MDFRCPC, Loretta J. Nastoupil, MD MSc, Yibo Li, MD, Gao Feng, Matthew A. Lunning, DO, FACP, Lazaros J Lekakis, MD, Saurabh Dahiya, MD, Patrick M Reagan, MD, Olalekan O. Oluwole, MBBS, MPH, Joseph P. McGuirk, DO, Abhinav Deol, MD, Alison R. Sehgal, MD, Andre Goy, MD, Brian T. Hill, MD, Charalambos Andreadis, MD MSCE, Javier Munoz, MD, Julio Chavez, N. Nora Bennani, MD, Aaron P. Rapoport, Julie M Vose, MDMBA, David B Miklos, MD PhD, Sattva S Neelapu, MD, Armin Ghobadi, MD, Frederick L. Locke, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1583.
https://doi.org/10.1182/blood-2019-131168
Published: 2019
Journal Articles

Long-Term Outcomes with Ibrutinib Versus the Prior Regimen: A Pooled Analysis in Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) with up to 7.5 Years of Extended Follow-up

Simon Rule, Martin H. Dreyling, MD PhD, Andre Goy, MD, Georg Hess, Rebecca Auer, MRCP, FRPath, PhD, Brad S. Kahl, MD, Jose Angel Hernandez-Rivas, MD PhD, Keqin Qi, PhD, Sanjay Deshpande, Lori Parisi, Michael L. Wang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1538.
https://doi.org/10.1182/blood-2019-124691
Published: 2019
Journal Articles

The Unforeseen Medical and Business Challenges Found When Integrating Abstracted Data from Disparate EHR Systems While Building the Curecloud Direct-to-Patient Multiple Myeloma Registry

Steven E. Labkoff, MD, Shaadi Mehr, PhD, Christopher Williams, Daniel Auclair, Paul A. Giusti, MBA, Kathy E. Giusti, MBA, Stuart L. Goldberg, MD, Kevin M Keogh, Andrew J. Belli, MPH, Andrew D Norden, MDMPH MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 4736.
https://doi.org/10.1182/blood-2019-130276
Published: 2019
Journal Articles

KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results of the Phase 2 ZUMA-2 Study

Michael L. Wang, MD, Javier Munoz, MD, Andre Goy, MD, Frederick L. Locke, MD, Caron A. Jacobson, MD MMSc, Brian T. Hill, MD, John M. Timmerman, MD, Houston Holmes, MD, Samantha Jaglowski, MDMPH, Ian W. Flinn, MD PhD, Peter A. McSweeney, MD, David B. Miklos, MD PhD, John M. Pagel, MD PhD DSc, Marie Jose Kersten, MD PhD, Weimin Peng, MS, Lianqing Zheng, PhD, John M. Rossi, MS, Rajul K. Jain, MD, Arati V. Rao, MD, Patrick M Reagan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 754.
https://doi.org/10.1182/blood-2019-126064
Published: 2019
Journal Articles

Evomela® Significantly Increases the Risk of Engraftment Syndrome in Patients with Multiple Myeloma Treated with Autologous Stem Cell Transplantation

Marshall McKenna, MD, Phyllis McKiernan, David S. Siegel, Scott D. Rowley, MD, Noa Biran, MD, David H. Vesole, MD PhD, Stuart L. Goldberg, MD, Themba Nyirenda, PhD, Andrew L. Pecora, MD, Andre Goy, MD, Michele L. Donato, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3316.
https://doi.org/10.1182/blood-2019-132114
Published: 2019
Journal Articles

Elotuzumab As Post-Autologous Stem Cell Transplant Consolidation in Patients with High-Risk Myeloma

Nikhita Gadi, MDMSc, Linda Schmidt, RN, Jaeil Ahn, PhD, Tianmin Wu, MS, Scott D. Rowley, MD, Elli Gourna Paleoudis, PhD, Michele L. Donato, MD, David H. Vesole, MD PhD, Stuart L. Goldberg, MD, David S. Siegel, Noa Biran, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3141.
https://doi.org/10.1182/blood-2019-129504
Published: 2019